Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.040
+0.020 (1.96%)
At close: Oct 5, 2026, 4:00 PM EDT
1.040
0.00 (0.00%)
Pre-market: Oct 6, 2026, 4:00 AM EDT
Metagenomi Therapeutics Market Cap
Metagenomi Therapeutics has a market cap or net worth of $39.29 million as of October 5, 2026. Its market cap has decreased by -60.50% in one year.
Market Cap
39.29M
Enterprise Value
-43.66M
1-Year Change
-60.50%
Ranking
Category
Stock Price
$1.04
ChartMarket Cap Chart
Since the IPO on February 9, 2024, Metagenomi Therapeutics's market cap has decreased from $562.92M to $39.29M, a decrease of -93.02%. That is a compound annual growth rate of -63.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 39.48M | -35.10% |
| Dec 31, 2025 | 60.83M | -54.98% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Impact BioMedical | 46.99M |
| Werewolf Therapeutics | 45.43M |
| Veru Inc. | 44.33M |
| Grace Therapeutics | 43.75M |
| CEL-SCI | 43.09M |
| Lite Strategy | 42.87M |
| Filana Therapeutics | 42.46M |
| Actinium Pharmaceuticals | 38.04M |